US Patent Issued to QINGDAO VLAND BIOTECH, QINGDAO VLAND BIOTECH GROUP on Feb. 17 for "Bacillus coagulans having blood glucose reduction efficacy, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,513, issued on Feb. 17, was assigned to QINGDAO VLAND BIOTECH INC. (Shandong, China) and QINGDAO VLAND BIOTECH GROUP Co. LTD. (Shandong, China).

"Bacillus coagulans having blood glucose reduction efficacy, and application thereof" was invented by Zhi Duan (Shandong, China), Hongchang Cui (Shandong, China), Songjie Wu (Shandong, China), Jingyan Zhang (Shandong, China) and Luxia Zhang (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a Bacillus coagulans strain VHProbi C08 having a blood glucose reduction efficacy and an application thereof in preparation of a hypoglycemic product. The accession number of the strain is CCTCC...